Methyl iodide → 4-(2-Ethoxy-2-oxoethyl)-1,1-dimethyl-4-(3-(4-octylphenyl)ureido)piperidinium iodide
反応式
[CH3:1][N:2]1[CH2:7][CH2:6][C:5]([CH2:26][C:27]([O:29][CH2:30][CH3:31])=[O:28])([NH:8][C:9]([NH:11][C:12]2[CH:17]=[CH:16][C:15]([CH2:18][CH2:19][CH2:20][CH2:21][CH2:22][CH2:23][CH2:24][CH3:25])=[CH:14][CH:13]=2)=[O:10])[CH2:4][CH2:3]1.[CH3:32][I:33]>C(Cl)Cl>[I-:33].[CH2:30]([O:29][C:27](=[O:28])[CH2:26][C:5]1([NH:8][C:9]([NH:11][C:12]2[CH:17]=[CH:16][C:15]([CH2:18][CH2:19][CH2:20][CH2:21][CH2:22][CH2:23][CH2:24][CH3:25])=[CH:14][CH:13]=2)=[O:10])[CH2:6][CH2:7][N+:2]([CH3:32])([CH3:1])[CH2:3][CH2:4]1)[CH3:31]参加物
4
実験手順
A solution of ethyl 2-(1-methyl-4-(3-(4-octylphenyl)ureido)piperidin-4-yl)acetate (73 mg, 0.169 mmol) in CH2Cl2 (5 mL) was treated with MeI (0.11 mL, 1.69 mmol) and the reaction stirred overnight at room temperature. The solvent was removed in vacuo to yield crude title compound (95 mg, 98%) which was used without further purification. 1H NMR (400 MHz, CDCl3) δ 8.35 (bs, 1H), 7.42 (d, 2H, J=8.4 Hz), 7.05 (d, 2H, J=8.4 Hz), 6.49 (bs, 1H), 4.39-4.32 (m, 2H), 4.14 (q, 2H, J=7.2 Hz), 3.41-3.34 (m, 5H), 3.21 (s, 2H), 3.20 (s, 3H), 2.64-2.41 (m, 6H), 1.29-1.20 (m, 13H), 0.89 (t, 3H, 6.4 Hz); MS ESI 446.4 [M]+, calcd for [C26H44N3O3]+ 446.65.
後処理
- customThe solvent was removed in vacuo
出典と根拠
- ORDレコード
- ord-4994e647745f44b6a610b78afda9e35f
- 出典データセット
- uspto-grants-2014_03
- 特許番号
- US08680282B2
反応ノート
読み込み中…